\BOOKMARK [2][-]{subsection.0.1}{Dirichlet Process Gaussian Mixture Model}{}% 1
\BOOKMARK [2][-]{subsection.0.2}{Hydra Method}{}% 2
\BOOKMARK [2][-]{subsection.0.3}{Pediatric Cancer Gene Expression Data}{}% 3
\BOOKMARK [2][-]{subsection.0.4}{TARGET Neuroblastoma Analysis}{}% 4
\BOOKMARK [2][-]{subsection.0.5}{Small Round Blue Cell Tumor Analysis}{}% 5
\BOOKMARK [2][-]{subsection.0.6}{Statistical Analysis}{}% 6
\BOOKMARK [2][-]{subsection.0.7}{H\046E Slide Preparation and Pathologist Review}{}% 7
\BOOKMARK [2][-]{subsection.0.8}{Performance Assessment using Synthetic Gene Expression Data}{}% 8
\BOOKMARK [2][-]{subsection.0.9}{Hydra Analysis of High-Risk Neuroblastoma Identifies Distinct Tumor Microenvironment States}{}% 9
\BOOKMARK [2][-]{subsection.0.10}{N-of-1 Tumor Analysis for Pediatric Neuroblastoma}{}% 10
\BOOKMARK [2][-]{subsection.0.11}{Hydra Analysis Discovers Complex Tissue Signatures}{}% 11
\BOOKMARK [2][-]{subsection.0.12}{Hydra Analysis Reveals Related Expression Subtypes Across Pediatric Cancers}{}% 12
